Patent ID: 7638551
Filing Date: 2009-12-29
Classification: A61P,C07D,C07F,Y02P

Abstract:
1. A method for the treatment of an immunology-related disease selected from the group consisting of Crohn's disease, ulcerative colitis, multiple sclerosis, atopic dermatitis, insulin dependent diabetes mellitus, glomerular nephritis and rejection of a transplanted organ or transplanted skin, in a mammal in need thereof which comprises administering to said mammal a pharmaceutically effective amount of a compound, a pharmacologically acceptable salt of the compound or a pharmacologically acceptable ester of the compound, wherein the compound is a compound having a formula (Ia) wherein R R R n is 2; X is ═N—D, wherein D is a hydrogen atom, a C Y is an ethylene group, an ethynylene group, a group of a formula CO—CH Z is an ethylene group or a trimethylene group; R R